SUMMARY
The Fund rose 2.3% in October, outperforming the Small Industrials by 0.9% and outperforming the Small Ordinaries by 0.4%. For the 12 months to October, the Fund was up 23.2%, outperforming the Small Industrials by 7.4% and outperforming the Small Ordinaries by 0.4%.




COMMENTARY
October was a firm month across most equity markets, with the US index up 2.3%, driven primarily by a 4.7% rise in the NASDAQ. Bond markets also strengthened in light of a second consecutive interest rate cut in the US. The gold price was largely flat over the month following a spectacular rise this year.
The Australian equity market rose 0.4%, driven by a 3.9% rally in resources stocks. In contrast to recent months, gold stocks were not the source of strength in the mining sector, as the iron ore and lithium sectors found strong support. Small-cap stocks in Australia rose 1.9% with resources mildly outperforming industrials.
Our positive contributors in October included:
Symal (+32%), which is a small position in our Fund, was awarded a large road upgrade project in Queensland. Regis Healthcare (+23%) recovered from heavy losses in September due to a potential over-reaction to a funding change. Praemium (+20%) and HUB24 (+13%) both reacted positively to quarterly flow update releases. ALS Ltd (+13%) continued to rally on the expectation of higher gold exploration activity.
Our negative contributors in October included:
Beacon Lighting (-14%) revealed softer short-term trading conditions at its AGM. ZIP Co (-12%) retraced after a 50% rally this year. Charter Hall (-2%), Technology One (-4%), and CAR Group (-3%) drifted in the absence of any stock-specific news.